Dengue, a mosquito-borne viral disease, poses a global threat owing to the unavailability of any specific therapeutics. Since prevention is only restricted to vector control, a clear understanding of Dengue Virus (DENV) transmission within an infected host is essential. The dynamics of DENV transmission addressed in light of molecular communication paradigm is promising in providing crucial information accounting for disease control that can lead to development of novel approaches to clear the virus infection. In this work, we model the DENV transmission inside the body from the point of a mosquito bite to the targeted organs as a communication system. Based on the physiological processes involved in the transmission of DENV through the layers of skin and vascular systems, we identify and propose a channel model. By considering the dynamics of virus transmission through the channel, we analyze and calculate different channel phenomena, such as path loss and channel noise, and obtain an analytical expression for the capacity of the proposed channel model. The uncertainty in signal transmission is modeled and evaluated owing to the innate and adaptive immune response in the channel. We performed in-silico experiments for validation and provided numerical analysis for the channel characteristics. Our analysis revealed that the attenuation offered in the cutaneous channel does not result in significant signal loss. We also observed that the variations in the channel capacity is not substantially affected by the injection probabilities of the virus.
INTRODUCTION
Nanomedicine provides a platform for significant development in disease monitoring, in-vivo drug delivery, therapeutic and diagnostic techniques, and can be realized via nano-networking and molecular communication. Dengue is one of the globally recognized critical and threatening diseases due to its pandemic nature in recent decades. It is an Aedes mosquito-borne infection transmitted to humans by Dengue virus DENV belonging to the Flaviviridae family. Dengue spread by five different serotypes, DENV-1, DENV-2, DENV-3, DENV-4, and DENV-5 from the virus family. These serotypes are antigenically distinct and produce a unique immune response to the infection in the host body. DENV approximately infects around 50 million people world-wide per year [1] . The core of Dengue virus is a positive single-stranded RNA genome inside a protein, encapsulated by a lipid envelope. The genome functions as mRNA (Messenger RNA) and conveys genetic information from DNA to any cell via vesicles for genome synthesis. The spread of multiple dengue serotypes from one organism to another increases the plausibility of genetic transformation. These RNA viruses have higher genetic recombination rate leading to the emergence of new virus serotype [2] . The continuous process of concurrent infections with distinct dengue virus serotypes and genetic transformations over the years has lead to novel challenges in dengue control. The developed dengue vaccine is effective only when it provides immunity against all the infectious variants of dengue serotype.
Currently, the vaccine available to treat dengue infection is not effective as the immunity against one serotype does not protect the host from other four serotypes. Moreover, being immune to one virus serotype while subsequently getting infected with another serotype triggers even more critical disease manifestations [3] . Also, a seronegative individual getting the vaccine for immunization develops a risk for subsequent severe dengue infection. According to WHO, a prior screening test and surveillance of infections from similar virus family is recommended before reaching out for vaccination [4] . Even if a vaccine is likely to be immunogenic to all the five serotypes identified, it may not be able to offer immunity against additional DENV serotypes which are in mutation cycle. The further discovery of such serotype would raise risk in the available dengue vaccine. The ever-increasing mortality rate due to the spread of infectious diseases has evoked the exigency for early identification as well as the progression of the illnesses. By recognizing the etiology of dengue fever, and the plausible steps involved in its pathogenesis, the early detection of the critical disease is possible. DENV plays a diverse role in the clinical manifestations. Since vaccination is yet not an effective tool to combat dengue, identifying the pathways of circulating virus serves to be beneficial. Moreover, detecting the underlying mechanisms leading to DENV infection aids in understanding the disease and its pathology. This would assist in accurate diagnosis, developing methods to counteract dengue, and producing an antiviral drug.
An essential question is whether we can model the propagation behavior of DENV, and in particular its impact as it propagates through various sub-systems of the human body. In this paper, we propose the use of molecular communication to model the propagation behavior of DENV inside a human body. We aim to define the propagation behavior through the use of communication metrics, such as an analytical channel model that can establish the propagation from the skin to the cellular compartments or organs. Based on the spread of the virus along different paths and limitations faced by the immune system, we derive the path loss model. Our molecular communication model links the spreading of the virus to the signal transmission, where the immune response is abstracted as the attenuation induced during transmission, while the target sites serve as the receiver.
Our work provides new insight into the propagation behavior of dengue virus infection, thereby, assisting biopharmaceutical industries in designing more efficient drugs or tools that can target specific vulnerable locations that the virus may be located. The following list constitutes the major research contributions of this paper:
• Modeling dengue transmission as an end-to-end abstraction of molecular communication channel: We propose a communication channel model for DENV transmission. The proposed channel model maps biological processes to major elements of a communication system. We evaluated the channel based on biomolecular kinetic processes. • Determining the influence of the channel on signal transmission:
We characterize a path loss model for signal transmission based on the effect of the host's physiological response. We also approximate a noise model for the channel. • Evaluating information theoretic-analysis of the channel: We analytically evaluate the capacity of the channel obtaining the expression for channel transition probabilities. Since the propagation of DENV to transport its internal RNA molecules to infect the host cell is equivalent to carrying information to the destination cell, we analyze the capacity of information transport.
RELATED WORK
Major efforts in the closely related area of DENV transmission are focused on the epidemiological models of disease transmission in human and vector populations. The relatively few works towards dengue infection considered monocytes as the only target for infection [5] , while assuming constant production rates for the same. However, it is observed that varying rate of monocyte production contributes to viral infection [6] . Few other works considered role of antibodies [7] and antiviral therapy [8] during viral infection. Recent attempts in exploring dengue infection typically deal with the aspects of virology and immunology. Our work is distinct with respect to modeling virus transmission as a communication system using concepts from molecular communication. Few works related to drug delivery systems model the channel through the molecular communication paradigm [9, 10] . The proposed model maps the physiological and bio-molecular processes into the communication elements. We develop the channel model to identify the dynamics in signal transmission towards multiple receivers and characterize the channel.
DENV TRANSMISSION MODEL
We model the transmission of DENV within a host body as a communication system. The source for the signal of the system is generated when the female mosquito bites and infects the human body. By using the direct cell-to-cell transmission strategy, DENV propagates through the cells and vascular network to the blood cells, and reaches various organs. The pathogenesis of dengue modeled as a communication system which is shown in Fig. 1 , broadly includes the following communication elements:
• Transmitter: It represents the proboscis of the infected female mosquito containing dengue virus along with the saliva that enter the skin in search of blood. The common source for signal transmission in our conceptualized system is the point when the mosquito bites the skin of a human and injects the virus into the body. We assume only one serotype of dengue virus is injected. The source signal, denoted by V (t ), composed of three distinct virulence of the serotype, which is partitioned into three mutually exclusive sets,
representing immature, partially mature and fully mature virus, respectively, which differs from each other based on their maturation level. The V im and V pm fuses into the host cells to undergo subsequent steps of maturation and cleaving to transform into a V f m . Typically, during each mosquito bite, around 10 4 to 10 6 of virus particles capable of infection gets injected into the host body [11] . • Channel: During several biting by the mosquito, majority of virus escapes into the epidermis and dermis layers of the skin, while relatively small amount of virus reaches the bloodstream [1] . Thus the channel can be categorised into two subchannels:
(1) Cutaneous, which consists of the epidermis and dermis layers of the skin cells and (2) Vascular, which consists of blood vessels for signal transmission. • Receiver: It is the set of sites such as, lymph nodes, bone marrow, and organs (liver, spleen, and lung) [12] , which receives the virus and gets affected with dengue. In this model, the strength of the signal at the receiver is defined as the timevarying number of virus particles present within the multiple receivers.
The DENV transmission in human body is abstracted as a communication model as conceptualized in Fig. 2 . The abstracted processes are further discussed in detail in following subsections.
Channel Modeling
The modeled communication channel is categorised into two subchannels. A proportion of the transmitted signal, V c goes into the cutaneous channel whereas the remaining of it V v goes into the vascular channel. Both the proportions from the source signal V are transmitted simultaneously over the subchannels. A part of the transmitted signal along the cutaneous channel escapes into the vascular channel after maturation. The signals from both the subchannels are multiplexed in the bloodstream before it reaches the multiple receivers.
(1) Cutaneous Channel: Typically, consists of Langerhans Cells (LCs) and Epithelial Cells (ECs) from the epidermis while the Dendritic Cells (DCs), tissue Macrophages (MPs), Mast Cells (MCs), and fibroblasts in dermis for cutaneous route of signal transmission [12] .
(2) Vascular Channel: The vascular route consists of interconnected blood and lymph vessels which includes the lymphocytes, monocytes, and macrophages of WBC, and platelets to transmit signal [12, 13] .
Since only selective mature virus has the ability to invade and replicate inside host cells, the transmitted signal propagating over both the subchannels undergo three major processesmaturation, ligand-receptor binding and replication of virus.
3.1.1 Maturation. The transmitter transmits a set of information particles {V im , V pm , V f m } into the channel. Along the channel, the immature and partially mature virus particles convert to fully mature virus particles in furin-dependent environment. We consider the immature virus convert into partial mature with a rate of δ im and eliminated with a phagocytic rate ρ im . In a similar manner, the partially mature virus convert and eliminate with rates δ pm and ρ pm , respectively whereas the mature virus is transmitted along the channel. Thus, the maturation of virus in channel is quantified with the following differential equation:
where  . is the virus injection rate and ρ f m is the elimination rate of V f m via phagocytosis.
3.1.2 Ligand-receptor binding. The virus is passed through the channel only when it get access to the host cell via binding. For a virus particle to enter into the intracellular environment, the particle's ligands must bind to the surface receptors of host cell. Thus, binding can be abstracted as filtering, following which the particles enter into the host via endocytosis and initiate replication. The process is majorly influenced by recognition and attachment between viral surface ligand and cellular surface receptor molecules which are usually electrostatic in nature. The overall process is facilitated by the factors such as the number of virus ligands n l , number of receptors n r , and binding rate r . The ligand-receptor interaction is basically the intermolecular attraction exploited by the biomolecular kinetics, where the number of ligand-receptor complexes n c formed is given by [14] dn c dt = rn l (n r − n c )
The binding site where the ligand-receptor comes into physical contact is referred to as the interface. This interface often witnesses defensive strategies, such as the random fluctuation in density of the fluidic environment characterized by Gaussian noise triggering the receptor diffusion. By incorporating the noise model [14] , the effective number of receptors is given as n r (t ) =n r + σ ξ (t ), wheren r is the average number of receptors, σ 2 is the noise intensity, and ξ (t ) is the Gaussian noise. The number of receptors n r fluctuates at the interface due to diffusion, thus effecting adversely in the formation of complexes. To account for these noisy effects on the binding, we model n c utilizing the noise in Eq. (4) as follows:
where D r corresponds to the receptor diffusion coefficient. Rewriting Eq. (5) in the differential form, we get the stochastic differential equation as:
where Gaussian noise being stationary has the mean term, ξ (t ) = 0. By solving Eq. (6) the solution is obtained as follows:
3.1.3 Replication of virus. The endocytosis and replication of V , which produces more virus offsprings, are speculated as amplification of the signal. After entering into the host cell, V f m fuses with the endosomal membrane releasing its nucleocapsid containing singlestranded RNA into the cytoplasm. Following a series of steps at the endoplasmic reticulum (ER), the viral RNA is replicated, amplified, and formed into numerous V im to appear on the ER surface. These are then transported into the trans-Golgi network to release V f m thereby amplifying the signal [15] . At time t = 0, considering the closed group of N number of cells at the target site, N sc denotes the number of cells susceptible to receive the virus, while N ic are the cells already invaded by the virus. We assume there is no further virus injection from outside into the closed group during the course of virus transmission. In an interacting environment, the population growth of V f m and N sc forms a backdrop for the predator-prey model [16] . Considering susceptible host cells N sc as the prey and mature virus particles V f m as the predator, the corresponding densities after amplication is modeled as:
where α represents the growth rate of the susceptible host cells in the absence of virus particles, β denotes the transition rate from susceptible cells to infected cells, and φ stands for predation rate upon prey. The transition rate determined by the probability of successful binding is β = P (b). The parameter v e denotes the engulfing or endocytic rate, and C e represents the engulfing capacity of the host cell given the fact that diameter of the host cell is in µm while that of a virus particle is in nm, and the time t is measured in microseconds. The γ represents the growth rate of V f m inside the host cell depicting the amplification (virus replication) rate and d be its (predator) death rate. The transmission of DENV in the channels do not follow an entry-exit route from any cell; rather it scatters to the neighboring cells following a lateral transmission [11] . The virus particles replicate and undergo maturation inside the host cells, and newly formed virus cells are released, which infects the nearby cells. The lateral spread of infection accounts for the bandwidth of the signal. Thus the bandwidth is determined by the number of infected cells N ic in the channel at time t. Thus the signal bandwidth can be obtained from the following equation:
where r denotes the ligand-receptor binding rate while κ represents the rate at which the infected cells die.
Noise Characterization
It has been observed that vitamin D synthesis in cutaneous environment modulates immune response, decreasing the number of virus transmitted [17] thereby reducing the signal strength. In our model, the modulation of immune response is characterized as the noise factor that adds uncertainity to the propagation of signal. The signal is lost in the channel and do not reach the receivers. We thus consider Additive white Gaussian noise (AWGN) N(t ) to model the propagation noise. Thus the rate of signal propagation affected by noise along the channel is expressed as:
where N(t ) ∼ N (0, σ 2 v ) and σ 2 v is the noise intensity.
Path Loss

Path Loss in Cutaneous
Channel. DENV reaches several receiver sites through the bloodstream by utilizing the two channels discussed above. The propagation from the skin to the different receivers witnesses the immune system at each stage triggered by the cells. The path loss is abstracted as the loss of virus particles due to the immune response during the propagation along the channel. As the virus invades, the surface receptors produce antigens over the host cells marking the presence of virus particles, which in response triggers the innate immune response in the cutaneous channel. The path loss in the cutaneous channel is due to the innate immune response triggered with the production of signaling proteins such as interferons (IFNs) by LCs, chemokines by MCs, and cytokines by the ECs within few hours of infection [15, 18] . The innate attenuation (A i ) dynamics takes into account production and death rates of immune proteins that mediate the adaptive cellular attenuation A cel modeled as follows:
where a i is the attenuation rate of virus particles depicting the rate of production of immune proteins, i c represents the production rate of immune cells activated by immune proteins, and a r is the removal rate of the immune proteins.
Path Loss in Vascular
Channel. The increase in innate attenuation activating the adaptive (cellular and humoral) immune system allows for pertinacious attenuation to V f m transmission. The cascade of the immune response in the dermal cells stimulates cellular response (mediated by T cells, B cells, and natural killer (NK) cells) [15] as well as humoral response (mediated by antibodies) [19] accounting for the path loss in the vascular channel. For cellular attenuation (A cel ), we assume the decay rate to be negligible pertaining to the cytokine storm resulting in abnormal proliferation of attenuation.
where a c represents proliferation rate of immune cells. Upon activation of immune response around the cells, the fusion of V im and V pm into the host cells gets hindered, which is rendered by the term V im + V pm in Eqs. (12) and (13) . The attenuation originating from humoral response (A hmr ) is modeled as follows:
where η and η th denotes the production rate of antibodies and threshold parameter that the antibodies must exceed to attenuate the virus. In this case, the factor A hmr V f m accounts for the clearance rate of antibodies by the virus. Thus the total path loss in the vascular channel, which is abstracted through a diffusion model in a fluidic medium is obtained as A v = A cel + A hmr .
CAPACITY ANALYSIS
In the modeled channel, the transmitter injects virus V consisting of three symbols represented as {V im , V pm , V f m }, whereas the virus O received by the receiver consists of two symbols represented as {O pm , O f m }, where im, pm, and f m refers to the immature, partially mature, and fully mature virus particles, as shown in Fig. 3 . We consider the virus symbols at the transmitter are injected with probabilities p i , p p , and p f , respectively. While traversing the channel, the immature virus particles undergo maturation, and therefore, they cannot be found at the receiver end. Hence, there are two symbols at the output of the channel: O pm and O f m . Since the fully mature virus particles do not undergo any maturation, the transition probability p(O f m |V f m ) is p 32 = 1. The dynamics of virus maturity is broadly described by the three major states characterized by -immaturation, partially maturation and fully maturation. The partially mature and fully mature virus is determined by the presence of uncleaved prM (pre-membrane) protein in the former, while cleaved prM in the latter [20] . We consider the dynamics of virus maturity to be represented as a continuous-time discrete-state Markov process with the aforementioned three states, which are denoted as S 1 , S 2 , and S 3 . The state transition probabilities between the states are denoted as a 12 , a 13 , a 22 , and a 23 , which are shown in Fig. 4 . In state S 1 , the immature virus particles fuse with the cell membrane with the rate δ f n and enter into the host cells in order to undergo maturation. The states S 2 and S 3 represent the partially maturation and fully maturation of the virus particles, respectively. Thus, we can map the state transition probabilities into the channel's transition error probabilities as a 12 = p 11 , a 13 = p 12 , a 22 = p 21 , and a 23 = p 22 . The state transition probabilities p 11 and p 22 can be obtained from the transition rates for the influx and outflux of V im , V pm , and V f m [21] which is given as follows:
where δ im and δ pm are the conversion rates from S 1 to S 2 and from S 2 to S 3 , respectively. The rates δ im and δ pm corresponds to the transition rate as discussed in Section 3.1.1. By using the above description of the channel, we get the joint symbol probabilities p(V j , O k ) as: 
The mutual information is obtained as follows:
The information-theoretic capacity of the channel with virus at the transmitter V and virus at the receiver O, which is defined as the maximum mutual information I (V ; O ) over the symbol probability p v ∈ (p i , p p , p f ), is given by:
where p i , p p , and p f are the injection probabilities of different set of virus at the transmitter.
NUMERICAL ANALYSIS
We performed in-silico experiments to evaluate the channel performance in terms of signal transmission, attenuation along the channel, and capacity of the channel. The Python-based simulations are carried out to numerically solve the set of ordinary differential equations defining the proposed channel. The values against the parameters used in the simulation, which are collected from the existing literature [5, 22, 23] are listed in Table 1 . In each simulation, a set of 10 4 virus (the value commonly taken for DENV based experiment [11] ) and 100 susceptible cells in the vicinity are considered in a confined area. In the modeled channel, the time considered is in days depicting the transmission of the dengue virus (signal). 15 The variation of signal strength during the transmission along the channel is shown in Fig. 5 . We estimated the endocytic rate and engulfing capacity to be 0.8 and 1, respectively, while the death rate of the virus was estimated to be 300 concerning the initial injection of 10 4 virus particles. It was observed that initially, the concentration increases and then reaches a fixed value, which is referred to as equilibrium. However, the concentration of host cells shows a contrasting behavior. As the virus continues invading susceptible host cells, the concentration of host cells decreases and then gradually tends to increase with the onset of the immune response. The frequency-domain representation of the signal (combination of immature, partially mature, and fully mature virus at injection time) is shown in Fig. 6 . The signal strength refers to the concentration of virus particles along the channel over the time period measured in days. It was noted that the signal strength decreased gradually with time due to the rapid increase in immune response in both the channels, resulting in the attenuation of the signal, as shown in Fig.  7 . It was also observed that in the cutaneous channel, the signal attenuates in the initial period following injection, while the signal attenuates more in a later time in the vascular channel. The signal (concentration of virus particles) is stronger initially when the value is close to zero in a negative dB scale. The higher the attenuation value, the more the likelihood of degradation in signal strength. Fig.  8 shows the trend of the channel capacity with the variation of the symbol probabilities with which the virus particles get injected inside the human body. It was observed that the value of channel capacity reaches the maximum when the condition of symbol probabilities, p i < p p < p f , holds. The influence of V f m is found to be greater than its counterparts (V im and V pm ) at the receiver. Since all the input symbol has equal probability for p i = p p = p f , the capacity is restrained at one point.
CONCLUSION
In this work, we proposed an end-to-end communication system for DENV proliferation inside a human body. The modeling and analyses provide crucial information on the change in the profile of the virus during their transmission, which plays a key role for the development of novel mechanisms to stop the spread of the dengue virus. We evaluated the proposed channel model by showing the variation of different channel characteristics with time such as attenuation, signal strength, and the channel capacity. In the future, we intend to explore the impact of time-varying channel conditions on the achievable maximum rate. We also plan to include noise that the channel encounters in the fluidic environment in order to get an in-depth insight into the DENV proliferation inside the body.
